Hu Ming-Luen, Wu Keng-Liang, Changchien Chi-Sin, Chuah Seng-Kee, Chiu Yi-Chun
Ming-Luen Hu, Keng-Liang Wu, Chi-Sin Changchien, Seng-Kee Chuah, Yi-Chun Chiu, Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.
World J Gastroenterol. 2017 Mar 28;23(12):2194-2200. doi: 10.3748/wjg.v23.i12.2194.
To observe the natural course of 1-3 cm gastric submucosal tumors originating from the muscularis propria (SMTMPs).
By reviewing the computerized medical records over a period of 14 years (2000-2013), patients with 1-3 cm gastric SMTMPs who underwent at least two endoscopic ultrasound (EUS) examinations were enrolled. Tumor progression was defined as a ≥ 1.2 times enlargement in tumor diameter observed during EUS surveillance. All patients were divided into stationary and progressive subgroups and further analyzed. We also reviewed the patients in the progressive subgroup again in 2016.
A total of 88 patients were studied, including 25 in the progressive subgroup. The mean time of EUS surveillance was 24.6 mo in the stationary subgroup and 30.7 mo in the progressive subgroup. Risk factors for tumor progression included larger tumor size and irregular border. Initial tumor size > 14.0 mm may be considered a cut-off size for predicting tumor progression. Seventeen patients underwent surgery, of whom 13 had gastrointestinal stromal tumors (GISTs) and 4 had leiomyomas. Tumor progression was found only in patients with GISTs. All of the tumors exhibited benign behaviors without metastasis until 2016.
Most 1-3 cm gastric SMTMPs (71.6%) are indolent. Tumor progression was found only in GISTs, and it is a good predictor for differentiating GISTs from leiomyomas. Predictors of tumor progression include larger tumor size (> 14.0 mm) and irregular border.
观察起源于固有肌层的1 - 3厘米胃黏膜下肿瘤(SMTMPs)的自然病程。
通过回顾14年(2000 - 2013年)的电子病历,纳入接受至少两次超声内镜(EUS)检查的1 - 3厘米胃SMTMPs患者。肿瘤进展定义为在EUS监测期间观察到肿瘤直径增大≥1.2倍。所有患者分为稳定组和进展组并进一步分析。我们还在2016年对进展组患者进行了再次评估。
共研究了88例患者,其中进展组25例。稳定组EUS监测的平均时间为24.6个月,进展组为30.7个月。肿瘤进展的危险因素包括肿瘤较大和边界不规则。初始肿瘤大小> 14.0毫米可被视为预测肿瘤进展的临界大小。17例患者接受了手术,其中13例为胃肠道间质瘤(GISTs),4例为平滑肌瘤。仅在GISTs患者中发现肿瘤进展。直到2016年,所有肿瘤均表现为良性行为,无转移。
大多数1 - 3厘米的胃SMTMPs(71.6%)呈惰性。仅在GISTs中发现肿瘤进展,这是区分GISTs和平滑肌瘤的良好预测指标。肿瘤进展的预测指标包括较大的肿瘤大小(> 14.0毫米)和不规则边界。